Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
The SCD1 inhibitor aramchol interacts with regorafenib to kill GI tumor cells in vitro and in vivo.
Journal: Oncotarget
Published: August 19, 2025
Systemic Therapy for Hepatocellular Carcinoma.
Journal: Clinics in liver disease
Published: November 28, 2024
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: September 16, 2022
Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab.
Journal: Journal for immunotherapy of cancer
Published: August 15, 2021
A Multi-institutional, Retrospective Analysis of Patients with Metastatic Renal Cell Carcinoma to Bone Treated with Combination Ipilimumab and Nivolumab.
Journal: Targeted oncology
Published: July 27, 2021
Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma.
Journal: Biomarker research
Published: July 19, 2021
Combination antiangiogenic tyrosine kinase inhibition and anti-PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes.
Journal: Cancer medicine
Published: December 03, 2020
Metastatic Hormone-Sensitive Prostate Cancer: A Review of the Current Treatment Landscape.
Journal: Cancer journal (Sudbury, Mass.)
Published: January 25, 2020
MRI predictors of tumor-positive margins after breast-conserving surgery.
Journal: Clinical imaging
Published: January 15, 2019
Predictors of Physical and Functional Loss in Advanced-Stage Lung Cancer Patients Receiving Platinum Chemotherapy.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 12, 2018
Last Updated: 09/26/2026